This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.
Tau Oligomer Platform Validation Using Lead Series Candidate in htau Mice Investments > €500k United States of America Alzheimer’s disease & other dementias 2016
Misfolded protein clearance enhancers for Alzheimers therapy Investments > €500k United States of America Alzheimer’s disease & other dementias 2016
Therapeutic potential of GMF suppresssion in inflammation and neurodegeneration Investments > €500k United States of America Alzheimer’s disease & other dementias 2016
A NOVEL NEUROPROTECTIVE THERAPY FOR ALZHEIMERS DISEASE Investments > €500k United States of America Alzheimer’s disease & other dementias 2016
A Novel Small molecule TNF-alpha inhibitor as a disease-modifying AD drug treatment. Investments > €500k United States of America Alzheimer’s disease & other dementias 2016
Integrative Biology Approach to Complexity of Alzheimers Disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016
A system approach to targeting innate immunity in AD Investments > €500k United States of America Alzheimer’s disease & other dementias 2016
ApoE4-targeted therapeutics that normalize SirT1 Investments > €500k United States of America Alzheimer’s disease & other dementias 2016
DEVELOPMENT OF NOVEL THERAPEUTIC ANTI-TAU ANTIBODIES Investments > €500k United States of America Alzheimer’s disease & other dementias 2016
A Translational Program of BDNF Gene Delivery in Alzheimers Disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016
